Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial
Titel:
Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial
Auteur:
Emens, Leisha A Esteva, Francisco J Beresford, Mark Saura, Cristina De Laurentiis, Michelino Kim, Sung-Bae Im, Seock-Ah Wang, Yifan Salgado, Roberto Mani, Aruna Shah, Jigna Lambertini, Chiara Liu, Haiying de Haas, Sanne L Patre, Monika Loi, Sherene